The Board of Directors of OPTUS Pharmaceutical Co., Ltd. has authorized a buyback plan on September 7, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,100 KRW | +3.74% | +1.16% | +14.66% |
1st Jan change | Capi. | |
---|---|---|
+14.66% | 71.25M | |
+15.54% | 78.51B | |
+12.05% | 9B | |
+58.17% | 4.96B | |
-14.94% | 4.84B | |
-.--% | 3.72B | |
+21.94% | 2.48B | |
-26.63% | 2.19B | |
+16.75% | 2.12B | |
-37.97% | 1.94B |
- Stock Market
- Equities
- A131030 Stock
- News OPTUS Pharmaceutical Co., Ltd.
- OPTUS Pharmaceutical Co., Ltd. authorizes a Buyback Plan.